In pancreatic ductal adenocarcinoma (PDA), the elevated expression of FAK showed a correlation with poor survival rates (Miyazaki et al., 2003; Itoh et al., 2004) and tumor size (Furuyama et al., 2006). This evidence concerns the gene PTK2 and pancreatic ductal adenocarcinoma.